NCT00922636
A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder
See it on ClinicalTrials.gov β340 people
29.4%
70.6%
100 womenmiddle line = equal numbers240 men
- Phase
- PHASE2, PHASE3
- Paid for by
- Eli Lilly and Company
- Finished
- 2010-12
- Health conditions
- Attention Deficit Hyperactivity Disorder
- Who could join
- Anyone
- Ages
- 6 Years β 17 Years
- Average age
- mean 11.63 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 72.6% Β· Black / African American 13.2% Β· More than one race 7.9% Β· Asian 5% Β· American Indian / Alaska Native 1.2% Β· Native Hawaiian / Pacific Islander 0% Β· Not reported 0%
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
βMaximum age: 17 Years.β
- No pregnant women
Women who were pregnant could not join.
βFemale patients who are pregnant or who are breast-feeding. Patients who have a history of Bipolar I/ II, psychosis, or pervasive developmental disorder.β
- No breastfeeding moms
Women who were breastfeeding could not join.
βFemale patients who are pregnant or who are breast-feeding. Patients who have a history of Bipolar I/ II, psychosis, or pervasive developmental disorder.β
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
βPatients of child-bearing potential agree to use a reliable method of birth control during the study and for 1 month following the last dose of study drug. Female patients of child-bearing potential must test negative for pregnancy at the tβ¦β
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
βPatients with problems that would be exacerbated by increased norepinephrine tone, including a history of cardiovascular disease, thyroid dysfunction, glaucoma, urinary retention, or severe gastrointestinal narrowing.β
- No seizures
Women with epilepsy or past seizures were turned away.
βPatients with a history of any seizure disorder, known electroencephalographic (EEG) abnormalities in the absence of seizures.β
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
βFemale patients who are pregnant or who are breast-feeding. Patients who have a history of Bipolar I/ II, psychosis, or pervasive developmental disorder.β
Study titles and rules are shown in their original English.